Skip to main content

Table 1 Patient cohorts characteristics, subdivided by fibrosis stage

From: Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients

Fibrosis stagea F0 F1 F2 F3 F4 All stages
Age b
Mean age SD 43.75 ± 12.11 44.83 ± 12.64 51.24 ± 12.04 57.10 ± 10.49 57.33 ± 11.31 49.30 ± 13.08
Gender c
Women 52 85 66 36 28 267
Men 45 91 69 31 39 275
Number of patients 97 176 135 67 67 542
HCV genotype c
1 70 126 100 50 43 390
2 2 12 1 1 3 19
3 11 25 12 5 7 60
4 0 4 4 1 0 9
Other 0 1 0 0 0 1
NA 14 8 18 10 14 64
  1. aHepatic fibrosis was assessed by examination of liver biopsies by an experienced pathologist and staged according to Desmet-Scheuer scoring system
  2. bFor the age, the mean value per fibrosis stage is reported along with the corresponding standard deviation
  3. cFor gender and HCV genotype absolute frequencies are given